Biology Reference
In-Depth Information
Abramoff M, Magalhaes P, Ram S (2004) Image Processing with ImageJ. J Biophotonics Int
11:36-42
Ackermann D, Heinsen H (1935) Über die physiologische Wirkung des Asterubins und anderer,
zum Teil neu dargestellter schwelfelhaltiger Guanidinderivate. Hoppe Seyles Z Physiol Chemie
235:115-121
Basciano H, Federico L, Adeli K (2005) Fructose, insulin resistance, and metabolic dyslipidemia.
Nutr Metab (Lond) 2:5. doi:doi: 10.1186/1743-7075-2-5
Bonora E, Targher G, Alberiche M et al (2000) Homeostasis model assessment closely mirrors the
glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with vari-
ous degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57-63
Carneiro EM, Latorraca MQ, Araujo E et al (2009) Taurine supplementation modulates glucose
homeostasis and islet function. J Nutr Biochem 20:503-511. doi:10.1016/j.
jnutbio.2008.05.008
Dokshina GA, Silaeva TI, Lartsev EI (1976) Insulin-like effects of taurine. Vopr Med Khim
22:503-507
El Mesallamy HO, El-Demerdash E, Hammad LN, El Magdoub HM (2010) Effect of taurine
supplementation on hyperhomocysteinemia and markers of oxidative stress in high fructose
diet induced insulin resistance. Diabetol Metab Syndr 2:46. doi:10.1186/1758-5996-2-46
Elizarova EP, Nedosugova LV (1996) First experiments in taurine administration for diabetes mel-
litus. The effect on erythrocyte membranes Adv Exp Med Biol 403:583-588
Franconi F, Bennardini F, Mattana A et al (1995) Plasma and platelet taurine are reduced in sub-
jects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am J Clin
Nutr 61:1115-1119
Franconi F, Loizzo A, Ghirlanda G, Seghieri G (2006) Taurine supplementation and diabetes mel-
litus. Curr Opin Clin Nutr Metab Care 9:32-36
Franconi F, Miceli M, Fazzini A et al (1996) Taurine and diabetes. Humans and experimental
models Adv Exp Med Biol 403:579-582
Hansen SH (2001) The role of taurine in diabetes and the development of diabetic complications.
Diabetes Metab Res Rev 17:330-346
Harada N, Ninomiya C, Osako Y et al (2004) Taurine alters respiratory gas exchange and nutrient
metabolism in type 2 diabetic rats. Obes Res 12:1077-1084. doi:10.1038/oby.2004.135
Kates M (1986) Techniques in Lipidology. Elsevier, New York, p 142
Kawano K, Hirashima T, Mori S et al (1992) Spontaneous long-term hyperglycemic rat with dia-
betic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes
41:1422-1428
Kim JY, Nolte LA, Hansen PA et al (1999) Insulin resistance of muscle glucose transport in male
and female rats fed a high-sucrose diet. Am J Physiol 276:R665-R672
Kim S-J, Gupta RC, Lee HW (2007) Taurine-diabetes interaction: from involvement to protection.
Curr Diabetes Rev 3:165-175
Kulakowski EC, Maturo J (1984) Hypoglycemic properties of taurine: not mediated by enhanced
insulin release. Biochem Pharmacol 33:2835-2838
Lau-Cam CA, Patel JP (2006) Comparison of the effects of taurine with those of related sulfur-
containing compounds on pyridoxal-induced adrenomedullary catecholamine release and gly-
cogenolysis in the rat. Adv Exp Med Biol 583:203-212
De Luca G, Calpona PR, Caponetti A et al (2001) Preliminary report: amino acid profile in plate-
lets of diabetic patients. Metab Clin Exp 50:739-741. doi:10.1053/meta.2001.24193
Lustig RH, Schmidt LA, Brindis CD (2012) Public health: the toxic truth about sugar. Nature
482:27-29. doi:10.1038/482027a
Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resis-
tance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
Diabetologia 28:412-419
Nakaya Y, Minami A, Harada N et al (2000) Taurine improves insulin sensitivity in the Otsuka
Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. Am J Clin Nutr
71:54-58
Search WWH ::
Custom Search